Official @neuralink Video Published 27 Jun 2025 Duration 59:59 ID FASMejN_5gs

Neuralink Update, Summer 2025: technical breakdown, key moments and clinical context

Published on 27 June 2025 ('Neuralink Update, Summer 2025', 59:59), this 12-chapter engineering keynote reviews the first 18 months of human clinical trials (covering the first 7 participants enrolled as of June 2025), multi-hour daily home usage, CONVOY robotic-arm control, neural decoding foundation models, preclinical macaque data for the Blindsight visual prosthesis, R1 surgical speed upgrades, and next-generation implant silicon.

27 Jun 2025Published dateOfficial @neuralink Video · 59:59

FASMejN_5gsYouTube Video IDChannel UCLt4d8cACHzrVvAz9gtaARA · Embeddable (200 OK)

Tier 1, 2 & 3Evidence classFlagship 1-Hour Progress Keynote

Clinical trials, keynotes & vision researchPrimary topicPaired with /neuralink/prime-convoy-voice-trials

Key points

Primary record: Official @neuralink video (FASMejN_5gs) published on 27 Jun 2025 (duration 59:59).
What it shows: Multi-participant human feasibility across spinal cord injury and ALS cohorts in the PRIME and CONVOY studies.
Technical pathway: Full-stack review: 7 human participants (Jun 2025), neural decoding, R1 robotics, Blindsight NHP data, and multi-implant roadmap.
Evidence boundary: 59:59 keynote mixing demonstrated human PRIME/CONVOY results with preclinical Blindsight and long-term roadmap goals.

Watch the official video record

Poster illustration for Neuralink Update, Summer 2025 — Source: Neuralink (@neuralink) · Channel UCLt4d8cACHzrVvAz9gtaARA · Video FASMejN_5gs · Checked 30 Oct 2026 Direct YouTube link ↗

Official upload from @neuralink (27 Jun 2025, 59:59).

Read verbatim official @neuralink YouTube description & caption provenance

Caption & verification basis: English manual + auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).

We’re translating neural signals into life-changing impact.

Join us to build the machine that builds the machine to merge with machines.
neuralink.com/careers

Learn more about our ongoing and future clinical trials:
neuralink.com/trials

00:00 Countdown
00:30 Intro & Overview (Elon)
12:39 Progress & Roadmap (DJ)
24:19 Our Participants (Sehej)
32:41 Robot Control & Body Reanimation (Elon)
35:07 Brain Computer Interfaces (Nir)
37:43 User Experience (Rooz)
40:32 Neural Decoding (Harrison)
45:02 Blindsight (Joey)
49:29 Robot (John)
53:14 Implant (Julian)
58:21 Closing (DJ & Elon)

Technical pathway and evidence classification

Video notes · 27 Jun 2025 · Video (59:59) Summer 2025 Comprehensive Update (PRIME, CONVOY, Blindsight, R1 & N1)

Technical pathway Signal & hardware chain

Full-stack review: 7 human participants (Jun 2025), neural decoding, R1 robotics, Blindsight NHP data, and multi-implant roadmap

Analytical scope What to keep in mind

59:59 keynote mixing demonstrated human PRIME/CONVOY results with preclinical Blindsight and long-term roadmap goals.

Timestamped breakdown and key moments

Sequential moments in Neuralink Update, Summer 2025 (59:59)
Timestamp	Segment / event	What happens in the segment
`00:30`	Intro & Overview (Elon Musk)	Frames the long-term bandwidth problem between biological brains and digital computing.
`12:39`	Progress & Roadmap (DJ Seo)	Reviews clinical trial expansion across PRIME and CONVOY and manufacturing scale.
`24:19`	Our Participants (Sehej)	Shares outcomes, daily usage hours, gaming, CAD, and testimonies from the first 7 human participants.
`35:07`	BCI Architecture, UX & Neural Decoding (Nir, Rooz, Harrison)	Details spike/LFP decoding, calibration reduction, and high-BPS cursor control.
`45:02`	Blindsight Preclinical Vision Update (Joey)	Presents non-human primate V1 microstimulation results where monkeys saccade to virtual phosphene targets.
`49:29`	R1 Robot & N1 Implant Engineering (John & Julian)	Covers next-gen surgical cartridge design, needle manufacturing, and custom ASICs.

What this video demonstrates—and what it does not establish

What this video demonstrates

Multi-participant human feasibility across spinal cord injury and ALS cohorts in the PRIME and CONVOY studies.
Preclinical behavioural validation of V1 cortical microstimulation in macaques for the Blindsight program.

Scope limits & what it does not establish

Clearly separate the human clinical segments (00:30–45:01) from the preclinical Blindsight segment (45:02–49:28) and long-term body-reanimation aspirations (32:41).

How this fits into Neuralink's broader clinical and hardware roadmap

This video sits inside the Clinical trials, keynotes & vision research research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Clinical trials, keynotes & vision research for cohort context.

Sources checked 30 Oct 2026

Sources and official records

[1] Neuralink YouTube (2025-06-27): Neuralink Update, Summer 2025 · Verified 30 Oct 2026
[2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) · Verified 30 Oct 2026
[3] Neuralink: Official website and investigational device notice · Verified 30 Oct 2026
[4] Neuralink: Clinical Trials and Patient Registry · Verified 30 Oct 2026
[5] ClinicalTrials.gov: The PRIME Study (NCT06429735) · Verified 30 Oct 2026
[6] Neuralink: Two Years of Telepathy (28 Jan 2026) · Verified 30 Oct 2026